$OCUL 4 SEC Filings

Filed On	Filing
13 Oct 2026	Form 4: Anderman Todd, Chief Legal Officer Sold 11,984 shares ($87.4K)
06 Oct 2026	Form 4: Kaiser Peter, Chief Development Officer Sold 9,990 shares ($70.4K)
06 Oct 2026	Form 4: Heier Jeffrey S., Chief Scientific Officer Sold 10,869 shares ($76.6K)
02 Sep 2026	Form 4: Notman Donald, Chief Operating Officer Sold 1,099 shares ($11.3K)
26 Aug 2026	Form 4: Kaiser Peter, Chief Development Officer Sold 3,035 shares ($32.7K)
26 Aug 2026	Form 4: Nayak Sanjay, Chief Strategy Officer Sold 1,897 shares ($20.4K)
26 Aug 2026	Form 4: Heier Jeffrey S., Chief Scientific Officer Sold 3,296 shares ($35.5K)
26 Aug 2026	Form 4: Dugel Pravin, Director Sold 21,649 shares ($233K) · Gave 50,092 shares as a gift · Acquired 50,092 shares (Gift)
18 Jun 2026	Form 4: Dugel Pravin, Director Gave 50,092 shares as a gift · Acquired 50,092 shares (Gift)
12 Jun 2026	Form 4: Robins Jason Shand, Chief Financial Officer Received 15,441 shares as a grant or award · Granted 14,024 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Graves Adrienne L, Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Warden Charles M, Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Lindstrom Richard L Md, Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Hong Seung Suh, Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Raines Merilee, Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
12 Jun 2026	Form 4: Williams Leslie J., Director Received 14,000 shares as a grant or award · Granted 44,000 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Waheed Nadia, Chief Medical Officer Sold 14,828 shares ($123K)
28 May 2026	Form 4: Dugel Pravin, Director Sold 21,156 shares ($173K) · Gave 394,696 shares as a gift · Acquired 394,696 shares (Gift)
28 May 2026	Form 4: Kaiser Peter, Chief Development Officer Sold 2,967 shares ($24.3K)
28 May 2026	Form 4: Heier Jeffrey S., Chief Scientific Officer Sold 3,018 shares ($24.7K)

Comments